Literature DB >> 24122132

Cellular mechanisms in intermittent hypoxia-induced cardiac damage in vivo.

Qian Han1, Sze C Yeung, Mary S M Ip, Judith C W Mak.   

Abstract

Obstructive sleep apnea (OSA), characterized by intermittent hypoxia (IH) during sleep, is increasingly recognized as an independent risk factor of cardiovascular diseases. OSA is associated with changes in the levels of circulating oxidative stress/inflammatory markers and dyslipidemia, supporting their mediating roles in cardiovascular pathogenesis. Our aims were to investigate the effect of IH on heart tissue using an IH-exposed rat model and to explore the potential mechanisms involved in the occurrence of cardiac damage. Male Sprague-Dawley rats were exposed to IH and intermittent normoxia as control and sacrificed after 2 or 4 weeks. IH for 4 weeks caused elevation in serum malondialdehyde and cytokine-induced neutrophil chemoattractant-1 and reduction in serum adiponectin levels. In contrast, cardiac oxidative stress and pro-inflammatory markers were suppressed while cardiac adiponectin and cholesterol levels were elevated after IH exposure for 4 weeks. In parallel, there was an increase in apoptosis in the heart of IH-exposed rats, demonstrated by elevations of Bax and cleaved caspase-3 protein and TUNEL staining. Cardiac damage was further evident with decreased arterial vessel and capillary densities, increased cardiac fibrosis, and the loss of troponin I. Our data demonstrated that IH exposure paradoxically caused systemic oxidative and inflammatory responses and cardioprotective responses, i.e., anti-oxidative and anti-inflammatory responses. Despite such a local compensatory protective mechanism, cardiac damage was observed that might be due to IH-induced cholesterol accumulation in the heart and caspase-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24122132     DOI: 10.1007/s13105-013-0294-z

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  42 in total

Review 1.  Cardiovascular consequences of sleep apnea.

Authors:  Bernardo Selim; Christine Won; H Klar Yaggi
Journal:  Clin Chest Med       Date:  2010-06       Impact factor: 2.878

2.  Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice.

Authors:  S F Yet; R Tian; M D Layne; Z Y Wang; K Maemura; M Solovyeva; B Ith; L G Melo; L Zhang; J S Ingwall; V J Dzau; M E Lee; M A Perrella
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

3.  Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.

Authors:  Giovanna E Carpagnano; Sergei A Kharitonov; Onofrio Resta; Maria P Foschino-Barbaro; Enzo Gramiccioni; Peter J Barnes
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

4.  Intermittent hypoxia induces hyperlipidemia in lean mice.

Authors:  Jianguo Li; Laura N Thorne; Naresh M Punjabi; Cheuk-Kwan Sun; Alan R Schwartz; Philip L Smith; Rafael L Marino; Annabelle Rodriguez; Walter C Hubbard; Christopher P O'Donnell; Vsevolod Y Polotsky
Journal:  Circ Res       Date:  2005-08-25       Impact factor: 17.367

Review 5.  Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences.

Authors:  Jacek Wolf; Joanna Lewicka; Krzysztof Narkiewicz
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-02-20       Impact factor: 4.222

Review 6.  Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system.

Authors:  Stephen J Peterson; William H Frishman; Nader G Abraham
Journal:  Cardiol Rev       Date:  2009 May-Jun       Impact factor: 2.644

7.  Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.

Authors:  Yasuhiko Nakagawa; Ken Kishida; Shinji Kihara; Mina Sonoda; Ayumu Hirata; Atsutaka Yasui; Hitoshi Nishizawa; Tadashi Nakamura; Ryoko Yoshida; Iichiro Shimomura; Tohru Funahashi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-15       Impact factor: 4.310

Review 8.  Cell death in heart failure.

Authors:  Kazuhiko Nishida; Kinya Otsu
Journal:  Circ J       Date:  2008-09-05       Impact factor: 2.993

Review 9.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

10.  Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats.

Authors:  Zhang Wang; Liang-Yi Si
Journal:  Ups J Med Sci       Date:  2013-02-26       Impact factor: 2.384

View more
  6 in total

1.  Protective role of downregulated MLK3 in myocardial adaptation to chronic hypoxia.

Authors:  Siyi He; Shunbi Liu; Xiaochen Wu; Mei Xin; Sheng Ding; Dong Xin; Hui Ouyang; Jinbao Zhang
Journal:  J Physiol Biochem       Date:  2017-05-30       Impact factor: 4.158

2.  Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling.

Authors:  Xueling Guo; Jin Shang; Yan Deng; Xiao Yuan; Die Zhu; Huiguo Liu
Journal:  Int J Mol Med       Date:  2015-04-24       Impact factor: 4.101

3.  Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease.

Authors:  Misa Valo; Annette Wons; Albert Moeller; Claudius Teupe
Journal:  Pulm Med       Date:  2015-05-18

4.  Haemin attenuates intermittent hypoxia-induced cardiac injury via inhibiting mitochondrial fission.

Authors:  Qian Han; Guihua Li; Mary SiuMan Ip; Yuelin Zhang; Zhe Zhen; Judith ChoiWo Mak; Nuofu Zhang
Journal:  J Cell Mol Med       Date:  2018-03-07       Impact factor: 5.310

5.  Cardioprotective Antioxidant and Anti-Inflammatory Mechanisms Induced by Intermittent Hypobaric Hypoxia.

Authors:  Alejandro González-Candia; Alejandro A Candia; Adolfo Paz; Fuad Mobarec; Rodrigo Urbina-Varela; Andrea Del Campo; Emilio A Herrera; Rodrigo L Castillo
Journal:  Antioxidants (Basel)       Date:  2022-05-25

6.  High-sensitivity cardiac troponin T in obstructive sleep apnea patients without cardiovascular diseases: Efficacy of CPAP treatment.

Authors:  Xiao-Bin Zhang; Hui-Qing Zeng; Yan-Ping Du; Zhi Lyu; Feng-Fu Zhan
Journal:  Chron Respir Dis       Date:  2017-11-08       Impact factor: 2.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.